SHORT TRADE

WIPRO

Cmp - 429.50

Add near - 427 To 429

T1 - 436
T2 - 440
T3 - 445++

TF - 2 TO 5 DAYS

S/L - 423 ON CBSL RISK REWARD FAVOURABLE

SAB MANDI MEIN HOGE & MKT WONT GIVE CHANCE TO BUY & MKT MEIN TEJI HOGI

ALL EXPECTING HUGE FALL ON BUDGET DAY OR AFTER BUDGET

NIFTY # 14750 TO 13713 DONE TILL NOW

LAST 2 BUDGET DATA

FY20 # - 2.5%

FY19 # - 1.1%

1 MONTH AVERAGE RETURNS OF LAST FOUR YEARS AFTER BUDGET ON NIFTY IS # -4% TO -5%

PAST DATA DOES NOT GIVE FUTURE GAURANTEE

HUGE VOLATILITY TO STAY FOR NEXT 1 TO 2 WEEKS

BUT AFTER BUDGET MARKET WOULD AGAIN WATCH OUT FOR Q3 & Q4 NUMBERS.

SENSEX HAS ALSO CORERECTED 50180 TO 46520

BANK NIFTY ALSO CORRECTED
32840 TO 29690

THIS IS COOL OFF & HEALTHY CORRECTION IN BULL MKT

MORE 3% TO 5% DOWNFALL POSSIBLE IN ALL INDICES ONLY IF NIFTY DIPS BELOW 13500

MARKETS ARE SUPREME

AARTI INDS

Q3FY21

UPDATE

Revenue up 9% at 1,142.6 crore Vs Rs 1,045.9 crore

Net profit up 18% at Rs 161.8 crore Vs Rs 136.8 crore

Ebitda up 11% at Rs 269.3 crore Vs Rs 242.8 crore

Ebitda margin at 23.6% Vs 23.2%

Specialty Chemicals revenue up 3% at Rs 1,029.1 crore Vs Rs 1,000.6 crore

Pharmaceutical revenue up 32% at Rs 232.2 crore Vs Rs 176.1 crore

Has constituted an internal Committee of Directors to evaluate the feasibility for demerger of Pharma and allied activities.

WIPRO

437.70 ✅

Trail with s/L of 432 for

440/445++

BEL

FY21 Q3 UPDATE

Consolidated net profit was up 24.9 percent at Rs 278 crore against Rs 222.7 crore (YoY). Consolidated revenue advanced 1.9 percent at Rs 2,320.4 crore against Rs 2,278.1 crore (YoY). Consolidated EBITDA gained 27.9 percent at Rs 456.2 crore against Rs 356.7 crore (YoY). Consolidated EBITDA margin stood at 19.7 percent against 15.7 percent (YoY).

Best stock for 2021 To 2022

INVESTMENT pick

BUY M&M FINANCE

Cmp - 150

Start adding in SIP

150 - 140 - 130

ALL TIME HIGH - 248

1 to 2 YRS DOWN THE LINE WOULD BE IN DIFFRENT ORBIT

50% upside possible in next 12 to 24 months

S/L - As per Risk

Disc - All views expressed are personal and only for educational and study purpose. Consult your financial advisor before investing or taking any position based on above article.

S/L hit above cost

Exit

AARTI INDS

1142 To 1193

Keep booking profits 📈 or

Trail for 1220/1260

MASTEK

1ST FEB Q3 NUMBERS WITH BUDGET DAY

TODAY GAINING MOMENUMT

4% 💚💚

M&M Finance

Moving 🐌 🦥 SLOWLY

159

🇮🇳 SEES FY22 GDP GROWTH AT 11%: SURVEY

INDIA FINANCE MINISTER TABLES ECONOMIC SURVEY IN PARLIAMENT

INDIA COMBINED FISCAL DEFICIT TO EXCEED TARGET IN FY21: SURVEY

🇮🇳 GROWTH RECOVERY TO BE DRIVEN BY GOVT. CONSUMPTION: SURVEY

SOLORA ACTIVE PHARMA

15% 💚💚

NEW 52WK HIGH

1544

NIFTY BELOW

13695

Now - 13608

13500 Need To Watch closely As its last support

MANY GOOD QUALITY STOCKS AVAILABLE AT THERE SUPPORT LEVELS AND GOOD FOR BOUNCE BACK

If 13500 violated Than 13295/13100 possible

MONDAY MKT MOVE AS PER BUDGET COMMENTRY

HUGE VOLATILITY EXPECTED

BEFORE BUDGET NIFTY DISCOUNTING MANY HIGH THINGS

BUDGET SECTORS TO KEEP WATCH

PHARMA
I.T
CHEMICALS
DEFENCE
CONSUMPTION STORY
INSURANCE

WIPRO

416 AFT OUR S/L HIT AT 432

WHY S/L VERY IMPORTANT IN SHORT TERM TRADES

DEEPAK NITRITE COMING IN FUTURE & OPTION